Werewolf Therapeutics Inc...

NASDAQ: HOWL · Real-Time Price · USD
1.09
0.10 (10.10%)
At close: May 15, 2025, 2:32 PM

Werewolf Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024
Reportable Segment Revenue 1.89M
Reportable Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 4.62M 4.6M 4.38M 4.53M 4.35M 4.31M 4.57M 4.98M 4.6M 4.44M 5.23M 4.42M 4.48M 4.01M 3.69M 2.63M 2.11M 1.24M 1.28M 1.13M
Selling, General, and Administrative Revenue Growth +0.54% +4.98% -3.40% +4.09% +1.02% -5.59% -8.35% +8.21% +3.69% -15.17% +18.37% -1.40% +11.88% +8.59% +40.08% +25.12% +69.70% -3.42% +13.62% n/a
Research and Development Revenue 15.73M 12.53M 15.27M 12.91M 9.65M 10.84M 9.58M 11.71M 15.86M 13.07M 13.89M 10.95M 13.4M 9.79M 7.26M 4.82M 5.29M 4.81M 3.78M 2.76M
Research and Development Revenue Growth +25.53% -17.96% +18.31% +33.78% -10.97% +13.10% -18.14% -26.19% +21.34% -5.88% +26.88% -18.32% +36.92% +34.71% +50.82% -8.87% +9.85% +27.30% +36.81% n/a